von Willebrand factor

Journal of Clinical Investigation

Volumn 100, Issue 11 SUPPL., 1997, Pages

  Ruggeri, Zaverio M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; VON WILLEBRAND FACTOR;

ANIMAL MODEL; BINDING SITE; GENETIC DISORDER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; THROMBOGENESIS; THROMBOSIS; VON WILLEBRAND DISEASE;

BLOOD PLATELETS; CELL ADHESION; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 0031471111     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Fuster, V., L. Badimon, J.J. Badimon, and J.H. Chesebro. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). [Review.] N. Engl. J. Med. 326:242-250.
2. Fuster, V., L. Badimon, J.J. Badimon, and J. H. Chesebro. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). [Review.] N. Engl. J. Med. 326:310-318.
3. Kroll, M.H., J.D. Hellums, L.V. McIntire, A.I. Schafer, and J.L. Moake. 1996. Platelets and shear stress. Blood. 88:1525-1541.
4. Tangelder, G.J., D.W. Slaaf, T. Arts, and R.S. Reneman. 1988. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am. J. Physiol. 254:H1059-H1064.
5. Back, C.H., J.R. Radbill, and D.W. Crawford. 1977. Analysis of pulsatile viscous blood flow through diseased coronary arteries of man. J. Biomech. 10: 339-353.
6. Ruggeri, Z.M., and J. Ware. 1993. von Willebrand factor. FASEB J. 7: 308-316.
7. Dent, J.A., S.D. Berkowitz, J. Ware, C.K. Kasper, and Z.M. Ruggeri. 1990. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc. Natl. Acad. Sci. USA. 87:6306-6310.
8. Dent, J.A., M. Galbusera, and Z.M. Ruggeri. 1991. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunil. J. Clin. Invest. 88:774-782.
9. Furlan, M., R. Robles, and B. Lammle. 1996. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 87:4223-4234.
10. Cruz, M.A., H. Yuan, J.R. Lee, R.J. Wise, and R.I. Handin. 1995. Interaction of the von Willebrand factor (vWF) with collagen. J. Biol. Chem. 270: 10822-10827.
11. Fujimura, Y., K. Titani, L.Z. Holland, J.R. Roberts, P. Kostel, Z.M. Ruggeri, and T.S. Zimmerman. 1987. A heparin-binding domain of human von Willehrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J. Biol. Chem. 262:1734-1739.
12. Christophe, O., B. Obert, D. Meyer, and J. Girma. 1991. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673. Blood. 78:2310-2317.
13. Denis, C., D. Baruch, C.M. Kielty, N. Ajzenberg, O. Christophe, and D. Meyer. 1993. Localization on von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. Arterioscl. Thromb. 13:398-406.
14. Fujimura, Y., K. Titani, L. Z. Holland, S.R. Russell, J.R. Roberts, J.H. Elder, Z.M. Ruggeri, and T.S. Zimmerman. 1986. von Willebrand factor. A reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J. Biol. Chem. 261:381-385.
15. Bahnak, B.R., Q. Wu, L. Coulombel, Z. Assouline, D. Kerbiriou-Nabias, G. Pietu, L. Drouet, J.P. Caen, and D. Meyer. 1989. Expression of von Willebrand factor in porcine vessels: Heterogeneity at the level of von Willebrand factor mRNA. J. Cell. Physiol. 138:305-310.
16. Nichols, T., C. Samama, D. Bellinger, J. Roussi, R. Reddick, and M. Bonneau. 1995. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc. Natl. Acad. Sci. USA. 92:2455-2459.
17. Savage, B., E. Saldivar, and Z.M. Ruggeri. 1996. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 84:289-297.
18. Nieuwenhuis, H.K., J.W.N. Akkerman, W.P.M. Houdijk, and J.J. Sixma. 1985. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (Lond.). 318:470-472.
19. Moroi, M., S.M. Jung, M. Okuma, and K. Shinmyozu. 1989. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J. Clin. Invest. 84:1440-1445.
20. Peterson, D.M., N.A. Stathopoulos, T.D. Giorgio, J.D. Hellums, and J.L. Moake. 1987. Shear-induced platelel aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 69:625-628.
21. Ikeda, Y., M. Handa, K. Kawano, T. Kamata, M. Murata, Y. Araki, H. Anbo, Y. Kawai, K. Watanabe, I. Itagaki, K. Sakai, and Z.M. Ruggeri. 1991. The role of von Willebrand Factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest. 87:1234-1240.
22. Weiss, H.J., J. Hawiger, Z.M. Ruggeri, V.T. Turitto, P. Thiagarajan, and T. Hoffmann. 1989. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J. Clin. Invest. 83:288-297.
23. Siedlecki, C.A., B.J. Lestini, K.Kottke-Marchant, S.J. Eppell, D.L. Wilson, and R.E. Marchant. 1996. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 88:2939-2950.
24. Goto, S., D.R. Salomon, Y. Ikeda, and Z.M. Ruggeri. 1995. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J. Biol. Chem. 270:23352-23361.
25. Jansson, J.H., T.K. Nilsson, and O. Johnson. 1991. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br. Heart J. 66:351-355.
26. Fuster, W., E.J. Bowie, J.C. Lewis, D.N. Fass, C.A.J. Owen, and A.L. Brown. 1978. Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. J. Clin. Invest. 61:722-730.
27. Nichols, T.C., D.A. Bellinger, R.L. Reddick, M.S. Read, G.G. Koch, K.M. Brinkhous, and T.R. Griggs. 1991. Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs. Circulation. 83:56-64.
28. Cooney, K.A., D. Ginsburg, and Z.M. Ruggeri. 1994. von Willebrand disease. In Thrombosis and Hemorrhage. J. Loscalzo and A. Schafer, editors. Blackwell Scientific Publications, Boston. 657-682.
29. Moake, J.L., C.K. Rudy, J.H. Troll, M.J. Weinstein, N.M. Colannino, J. Azacar, R.H. Seder, S.L. Hong, and D. Deykin. 1982. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocylopenic purpura. N. Engl. J. Med. 307:1432-1435.
30. Moake, J.L., J.J. Byrnes, J.H. Troll, C.K. Rudy, M.J. Weinstein, N.M. Colannino, and S.L. Hong. 1984. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with hemolytic-uremic syndrome. Blood. 64:592-598.
31. Scott, J.P., R.R. Montgomery, and G.S. Retzinger. 1991. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J. Biol. Chem. 266:8149-8155.
32. Read, M.S., S.V. Smith, M.A. Lamb, and K.M. Brinkhous. 1989. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood. 74:1031-1035.
33. Budde, U., R.E. Scharf, P. Franke, K. Hartmann-Budde, J. Dent, and Z.M. Ruggeri. 1993. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood. 82:1749-1757.
34. Nichols, T.C., D.A. Bellinger, T.A. Johnson, M.A. Lamb, and T.R. Griggs. 1986. von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circ. Res. 59:15-26.
35. Bellinger, D.A., T.C. Nichols, M.S. Read, R.L. Reddick, M.A. Lamb, K.M. Brinkhous, B.L. Evatt, and T.R. Griggs. 1987. Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor. Proc. Natl. Acad. Sci. USA. 84:8100-8104.
36. Yao, S.K., J.C. Ober, L.I. Garfinkel, Y. Hagay, N. Ezov, J.J. Ferguson, H.V. Anderson, A. Panet, M. Gorecki, L.M. Buja, and J.T. Willerson. 1994. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation. 89:2822-2828.
37. Zahger, D., M.C. Fishbein, L.I. Garfinkel, P.K. Shah, J.S. Forrester, J. Regnstrom, J. Yano, and B. Cercek. 1995. VCL, an antogonist of the platelet GP1b receptor, markedly inhibits platelet adhesion and intimal thickening after balloon injury in the rat. Circulation. 92:1269-1273.
38. Savage, B., S.J. Shattil, and Z.M. Ruggeri. 1992. Modulation of platelet function through adhesion receptors: A dual role for glycoprotein IIb-IIIa (integrin IIb 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J. Biol. Chem. 267:11300-11306.